BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4843340)

  • 1. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
    Ishibe T; Usui T; Nihira H
    J Urol; 1974 Aug; 112(2):237-40. PubMed ID: 4843340
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
    Fraley EE; Paulson DF
    Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
    [No Abstract]   [Full Text] [Related]  

  • 6. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoma of the prostate and lymphatic metastases.
    McCullough DL; Prout GR; Daly JJ
    J Urol; 1974 Jan; 111(1):65-71. PubMed ID: 4813555
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic carcinoma: reflections on its natural history, diagnosis, and therapy.
    Schirmer HK
    J Surg Oncol; 1969; 1(2):131-40. PubMed ID: 5406361
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.
    Byar DP; Mostofi FK
    Cancer; 1972 Jul; 30(1):5-13. PubMed ID: 5064808
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.
    Bailar JC; Byar DP
    Cancer; 1970 Aug; 26(2):257-61. PubMed ID: 4916020
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of the prostate. I. Histochemical examination as an aid in evaluating prostate carcinoma.
    Vrubel F; Mráz J; Nĕmecek R; Papousek F; Hanselová M
    Int Urol Nephrol; 1979; 11(4):295-9. PubMed ID: 536178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1973; 7(1):18-22. PubMed ID: 4701654
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 14. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
    Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
    J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal suppression in the treatment of carcinoma of the prostate.
    Robinson MR; Shearer RJ; Fergusson JD
    Br J Urol; 1974 Oct; 46(5):555-9. PubMed ID: 4422260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of serum acid phosphatase and its isoenzymes].
    Ishibe T; Usui T; Tanaka K
    Nihon Rinsho; 1976; 34 suppl():2521-35. PubMed ID: 792523
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
    Blackard CE; Doe RP; Mellinger GT; Byar DP
    Cancer; 1970 Aug; 26(2):249-56. PubMed ID: 4916019
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum acid phosphatase in the assessment of response to systemic therapy in metastatic prostate cancer: comparison of radioimmune and enzymatic assays.
    Ihde DC; Belville WD; Mahan DE; Gemski MJ; Eddy JL
    Mil Med; 1982 Nov; 147(11):949-52. PubMed ID: 6817183
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological and biochemical studies of virus (SV40) transformed prostatic tissue.
    Fraley EE; Paulson DF
    J Urol; 1969 May; 101(5):735-40. PubMed ID: 4305419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.